Found 113 matching trials
Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy N/A compare the efficacy and safety of intravenous iron sucrose versus chelated...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia NA The aim of this study is to determine the safety and therapeutic effect of ...
Show More Location
Riphah International University
Learn More & Join Trial
Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis PHASE4 This study employed a prospective, single-arm, global multi-center interven...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload PHASE4 This study will evaluate the safety and efficacy of deferasirox in transfus...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment PHASE2 The purpose of this trial is to evaluate changes in cardiac iron as measure...
Show More Location
Childrens Hospital of Los Angeles
Learn More & Join Trial
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia N/A Thalassemias are a heterogeneous grouping of genetic disorders that result ...
Show More Location
AL Zahar teaching Hospital
Learn More & Join Trial
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload PHASE1 The purpose of this research study is to study the safety of increasing dos...
Show More Location
Children's Hospital of Oakland
Learn More & Join Trial
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy N/A The investigate will conduct a cohort study to compare the growth and devel...
Show More Location
Regenerative Medicine Center
Learn More & Join Trial
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) PHASE2 The main aim of this study is to learn how safe elritercept is and how well...
Show More Location
Genesis Cancer and Blood Institute
Learn More & Join Trial
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload PHASE2 The purpose of this research study is to evaluate the safety of two doses o...
Show More Location
Children's Hospital and Research Center of Oakland
Learn More & Join Trial